Want to see RADX full AI Analyst Report?
Technical Sentiment
Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) Moving Averages Convergence Divergence (MACD) indicator is -0.39, suggesting Radiopharm Theranostics Limited Sponsored ADR is a Buy.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 20-Day exponential moving average is 2.90, while Radiopharm Theranostics Limited Sponsored ADR’s (RADX) share price is $3.66, making it a Sell.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 50-Day exponential moving average is 3.48, while Radiopharm Theranostics Limited Sponsored ADR’s (RADX) share price is $3.66, making it a Sell.
Radiopharm Theranostics Limited Sponsored ADR (RADX) Pivot Points
Classic
1.98
2.10
2.20
2.32
2.42
2.54
2.64
Fibonacci
2.10
2.19
2.24
2.32
2.41
2.46
2.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Radiopharm Theranostics Limited Sponsored ADR (RADX) Moving Averages
MA5
2.50Sell
2.48Sell
MA10
2.62Sell
2.61Sell
MA20
2.85Sell
2.90Sell
MA50
3.71Sell
3.48Sell
MA100
4.10Sell
3.95Sell
MA200
4.51Sell
4.51Sell
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 10-Day exponential moving average is 2.61, while Radiopharm Theranostics Limited Sponsored ADR’s (RADX) share price is $3.66, making it a Sell.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 100-Day exponential moving average is 3.95, while Radiopharm Theranostics Limited Sponsored ADR’s (RADX) share price is $3.66, making it a Sell.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) stock price is $3.66 and Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 50-day simple moving average is 3.71, creating a Sell signal.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) stock price is $3.66 and Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 100-day simple moving average is 4.10, creating a Sell signal.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) stock price is $3.66 and Radiopharm Theranostics Limited Sponsored ADR’s (RADX) 200-day simple moving average is 4.51, creating a Sell signal.
Radiopharm Theranostics Limited Sponsored ADR (RADX) Technical Indicators
RSI (14)
27.56
Buy
STOCH (9,6)
17.38
Buy
STOCHRSI (14)
11.53
Buy
MACD (12,26)
-0.39
Buy
ADX (14)
61.25
Sell
Williams %R
-77.15
Buy
CCI (14)
-124.18
Buy
ATR (14)
0.28
-
Ultimate Oscillator
39.19
Neutral
ROC
-21.54
Sell
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) Relative Strength Index (RSI) is 27.56, creating a Buy signal.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) Trend Strength Indicator (ADX) is 61.25, creating a Sell signal.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) Commodity Channel Index (CCI) is -124.18, creating a Buy signal.
Radiopharm Theranostics Limited Sponsored ADR’s (RADX) Price Rate of Change (ROC) is -21.54, creating a Sell signal.
FAQ
Is RADX a Buy, Hold, or Sell?
Based on RADX’s technical indicators, RADX is a Sell.
What is RADX’s RSI (14)?
RADX’s RSI (14) is 27.56, which suggests RADX is a Buy.
What is RADX’s MACD?
RADX’s MACD is -0.39, which suggests RADX is a Buy.
What is RADX’s 5-day moving average?
RADX’s 5-day moving average is 2.50, which suggests RADX is a Sell.
What is RADX’s 20-day moving average?
RADX 20-day moving average is 2.85, which suggests RADX is a Sell.
What is RADX’s 50-day moving average?
RADX’s 50-day moving average is 3.71, which suggests RADX is a Sell.
What is RADX’s 200-day moving average?
RADX’s 200-day moving average is 4.51, which suggests RADX is a Sell.
What is RADX’s Williams % R (14)?
RADX’s Williams % R (14) is -77.15, which suggests RADX is a Buy.
What is RADX’s CCI (14)?
RADX’s CCI (14) is -124.18, which suggests RADX is a Buy.